Jurors are set to enter a third day of deliberations on Thursday in the fraud trial of Elizabeth Holmes, the founder of the failed blood testing start-up Theranos.
Ms. Holmes, 37, faces two counts of conspiracy to commit wire fraud and nine counts of wire fraud for allegedly lying about Theranos’s technology to land money and fame. If convicted, she could serve up to 20 years in prison.
A jury of eight men and four women began deliberations on Monday and continued their discussions on Tuesday. Their sole question to the court, on Tuesday afternoon, was whether they could take jury instructions home. (The response was no.) They had Wednesday off.
If deliberations do not conclude on Thursday, they will resume at a date to be determined by the judge.
In Silicon Valley, start-up founders are rarely prosecuted for their truth-stretching claims. Ms. Holmes, who stood out as a female founder in the male-dominated industry, intentionally molded herself after Apple’s Steve Jobs. She started Theranos in 2003, dropped out of Stanford University to in 2004 and spent the next decade raising nearly $1 billion from venture capitalists and wealthy family offices.
In 2015, a Wall Street Journal investigation revealed that Ms. Holmes had overstated the capabilities of Theranos’s blood testing technology, as well as its relationships with pharmaceutical companies and the military. The company shut down in 2018.
The case boils down to whether Ms. Holmes meant to deceive investors, patients...
Immigration and Customs Enforcement on Tuesday announced is seeking to fine an immigration attorney who allegedly filed false asylum claims -- the first time the agency has filed such a claim. Home...